Pee Cee Cosma Sope Intrinsic Value
PCCOSMA Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹550.00 | ₹440.00 - ₹660.00 | +51.4% | EPS: ₹22.00, Sector P/E: 25x |
| Book Value Method | asset | ₹408.33 | ₹367.50 - ₹449.16 | +12.4% | Book Value/Share: ₹163.33, P/B: 2.5x |
| Revenue Multiple Method | revenue | ₹660.00 | ₹594.00 - ₹726.00 | +81.7% | Revenue/Share: ₹440.00, P/S: 1.5x |
| EBITDA Multiple Method | earnings | ₹314.67 | ₹283.20 - ₹346.14 | -13.4% | EBITDA: ₹8.00Cr, EV/EBITDA: 12x |
| Simple DCF (5Y) | dcf | ₹216.62 | ₹173.30 - ₹259.94 | -40.4% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹140.80 | ₹126.72 - ₹154.88 | -61.2% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹407.88 | ₹367.09 - ₹448.67 | +12.3% | Revenue Growth: 6.0%, Adj P/E: 18.5x |
| ROE Based Valuation | profitability | ₹373.33 | ₹336.00 - ₹410.66 | +2.8% | ROE: 16.3%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹284.34 | ₹255.91 - ₹312.77 | -21.7% | EPS: ₹22.00, BVPS: ₹163.33 |
Want to compare with current market value? Check PCCOSMA share price latest .
Valuation Comparison Chart
PCCOSMA Intrinsic Value Analysis
What is the intrinsic value of PCCOSMA?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Pee Cee Cosma Sope (PCCOSMA) is ₹373.33 (median value). With the current market price of ₹363.30, this represents a +2.8% variance from our estimated fair value.
The valuation range spans from ₹140.80 to ₹660.00, indicating ₹140.80 - ₹660.00.
Is PCCOSMA undervalued or overvalued?
Based on our multi-method analysis, Pee Cee Cosma Sope (PCCOSMA) appears to be trading near calculated value by approximately 2.8%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 28.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.18 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 16.3% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 6.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 2.28x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for Pee Cee Cosma Sope
Additional stock information and data for PCCOSMA
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹7 Cr | ₹4 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹10 Cr | ₹8 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹3 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹9 Cr | ₹4 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹0 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |